EP Patent

EP1471919B1 — Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist

Assigned to Glaxo Group Ltd · Expires 2005-08-10 · 21y expired

What this patent protects

A pharmaceutical composition comprising a compound of formula (I), or a solvate thereof, in combination with a muscarinic receptor antagonist.

USPTO Abstract

A pharmaceutical composition comprising a compound of formula (I), or a solvate thereof, in combination with a muscarinic receptor antagonist.

Drugs covered by this patent

Tudorza Pressair (ACLIDINIUM BROMIDE) · Covis

Patent Metadata

Patent number: EP1471919B1
Jurisdiction: EP
Classification: —
Expires: 2005-08-10
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.